Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

Authors:
  • ADA James M Daveson
    A James M Daveson
  • RSRichard Stubbs
    Richard Stubbs
  • TPThomas M Polasek
    Thomas M Polasek
  • JIJorma Isola
    Jorma Isola
  • RARobert Anderson
    Robert Anderson
  • JTJason A Tye-Din
    Jason A Tye-Din
  • MSMark Schoeman
    Mark Schoeman
  • CLClaudette Lionnet
    Claudette Lionnet
  • SMSwee Lin Chen Yi Mei
    Swee Lin Chen Yi Mei
  • JMJelena Mihajlović
    Jelena Mihajlović
  • MWMartina Wirth
    Martina Wirth
  • EPEvelyn Peelen
    Evelyn Peelen

Abstract
No abstract available

This publication has 23 references indexed in Scilit: